This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Vuyyuru SK, Kedia S, Sahu P, Ahuja V. Immunemediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis. JGH Open. 2022;6(2):100-11.Search in Google Scholar
Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79-94.Search in Google Scholar
Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. Journal of Translational Medicine. 2019;17(1):419.Search in Google Scholar
Kofla-Dlubacz A, Pytrus T, Akutko K, Sputa-Grzegrzolka P, Piotrowska A, Dziegiel P. Etiology of IBD-Is It Still a Mystery? Int J Mol Sci. 2022;23(20).Search in Google Scholar
Gajendran M, Loganathan P, Jimenez G, Catinella AP, Ng N, Umapathy C, et al. A comprehensive review and update on ulcerative colitis(). Dis Mon. 2019;65(12):100851.Search in Google Scholar
Lichtenstein GR, Shahabi A, Seabury SA, Lakdawalla DN, Espinosa OD, Green S, et al. Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis. Gastroenterol Hepatol (N Y). 2022;18(1):32-43.Search in Google Scholar
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences. 2022;23(2):786.Search in Google Scholar
Li W, Qiu X, Ma H, Geng Q. Incidence and long-term specific mortality trends of metabolic syndrome in the United States. Front Endocrinol (Lausanne). 2022;13:1029736.Search in Google Scholar
Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients. 2020;12(5).Search in Google Scholar
Jovanovic M, Simovic Markovic B, Gajovic N, Jurisevic M, Djukic A, Jovanovic I, et al. Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression. World J Gastroenterol. 2019;25(43):6465-82.Search in Google Scholar
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, et al. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2).Search in Google Scholar
Griesenauer B, Paczesny S. The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Frontiers in Immunology. 2017;8.Search in Google Scholar
Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cellular & Molecular Immunology. 2023;20(3):217-51.Search in Google Scholar
Rezaianzadeh A, Namayandeh SM, Sadr SM. National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease? Int J Prev Med. 2012;3(8):552-8.Search in Google Scholar
Ikeya K, Hanai H, Sugimoto K, Osawa S, Kawasaki S, Iida T, et al. The Ulcerative Colitis Endoscopic Index of Severity More Accurately Reflects Clinical Outcomes and Long-term Prognosis than the Mayo Endoscopic Score. J Crohns Colitis. 2016;10(3):286-95.Search in Google Scholar
Pabla BS, Schwartz DA. Assessing Severity of Disease in Patients with Ulcerative Colitis. Gastroenterol Clin North Am. 2020;49(4):671-88.Search in Google Scholar
Jauregui-Amezaga A, Geerits A, Das Y, Lemmens B, Sagaert X, Bessissow T, et al. A Simplified Geboes Score for Ulcerative Colitis. Journal of Crohn's and Colitis. 2016;11(3):305-13.Search in Google Scholar
Jovanovic M, Gajovic N, Jurisevic M, Markovic B, Maric V, Jovanovic M, et al. Fecal sST2 correlates with disease severity of ulcerative colitis. Vojnosanitetski pregled. 2018;76:26-.Search in Google Scholar
Scoville EA, Allaman MM, Brown CT, Motley AK, Horst SN, Williams CS, et al. Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling. Metabolomics. 2018;14(1):17.Search in Google Scholar
Ding W, Zou G-L, Zhang W, Lai X-N, Chen H-W, Xiong L-X. Interleukin-33: Its Emerging Role in Allergic Diseases. Molecules. 2018;23(7):1665.Search in Google Scholar
Drake LY, Kita H. IL-33: biological properties, functions, and roles in airway disease. Immunol Rev. 2017;278(1):173-84.Search in Google Scholar
Miller AM. Role of IL-33 in inflammation and disease. J Inflamm (Lond). 2011;8(1):22.Search in Google Scholar
Guo H, Bossila EA, Ma X, Zhao C, Zhao Y. Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions. Cells. 2022;11(20):3237.Search in Google Scholar
Griesenauer B, Paczesny S. The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Front Immunol. 2017;8:475.Search in Google Scholar
Lang T, Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunology & Cell Biology. 2007;85(6):425-34.Search in Google Scholar
Xiong X, Liao X, Qiu S, Xu H, Zhang S, Wang S, et al. CXCL8 in Tumor Biology and Its Implications for Clinical Translation. Front Mol Biosci. 2022;9:723846.Search in Google Scholar
Wera O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. Journal of Clinical Medicine. 2016;5(12):118.Search in Google Scholar
Meniailo ME, Malashchenko VV, Shmarov VA, Gazatova ND, Melashchenko OB, Goncharov AG, et al. Interleukin-8 favors pro-inflammatory activity of human monocytes/macrophages. Int Immunopharmacol. 2018;56:217-21.Search in Google Scholar
Ha H, Debnath B, Neamati N. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases. Theranostics. 2017;7(6):1543-88.Search in Google Scholar
Monserrat-Mesquida M, Quetglas-Llabres M, Capo X, Bouzas C, Mateos D, Pons A, et al. Metabolic Syndrome is Associated with Oxidative Stress and Proinflammatory State. Antioxidants (Basel). 2020;9(3).Search in Google Scholar
